This review will provide an exhaustive view of medication management models that could be effective for polymedicated , home-dwelling older adults and will allow us to analyze their impact on managing and preventing MRPs .
BACKGROUND Older adults with multiple chronic diseases commonly require complex medication regimes .
When combined with frailty , cognitive impairment , and changing pharmacological prescriptions , older adults ' polymedication regimes increase the risk of medication-related problems ( MRPs ) and hospitalization .
Effective , well-organized medication management could avoid MRPs and their clinical outcomes .
OBJECTIVE Identify medication management models and analyze their impact on managing and preventing MRPs for polymedicated , home-dwelling older adults .
Does the non-randomized controlled study have a place in the systematic review? A pilot study.
BACKGROUND A major issue in any systematic review is deciding which trials or studies to include and which to exclude . The Cochrane Collaboration and similar respected organizations have traditionally viewed the r and omized trial ( RCT ) as the only acceptable evidence on treatment outcome . However , many systematic review s are indeterminate because they include insufficient RCTs whilst they reject large numbers of non-r and omized controlled studies . This is particularly true in forensic mental health , a domain where RCT methodology can be problematic . Systematic review s could become more informative if review ers knew when , and under what circumstances , non-r and omized design s are acceptable for inclusion alongside RCTs . METHOD This pilot study explores whether good- quality , controlled , non-r and omized studies can be reliable surrogates for RCTs . We examined two published review s from the Cochrane Schizophrenia Group . We compared outcomes between ( a )  r and omized trials  ( that had been included ) and non-r  and omized studies  ( that had been excluded ) , and ( b ) between high- and low- quality studies using an established quality checklist  . RESULTS In the first review , effect scores were similar for r and omized and non-r and omized studies and relatively insensitive to study quality . In the second review , the treatment effect was considerably lower for the RCT group - here , however , studies of high- quality showed much smaller effect scores than those of low- quality on two separate outcomes . CONCLUSIONS Non-r and omized controlled studies of high quality can produce outcomes that approximate to those found in RCTs . Trial quality may have a greater impact on treatment effect size than r and omization alone , suggesting that r and omization should not be seen as a reliable proxy for overall quality . The problems and issues still to be resolved are discussed with recommendations for future research
This review will provide an exhaustive view of medication management models that could be effective for polymedicated , home-dwelling older adults and will allow us to analyze their impact on managing and preventing MRPs .
BACKGROUND Older adults with multiple chronic diseases commonly require complex medication regimes .
When combined with frailty , cognitive impairment , and changing pharmacological prescriptions , older adults ' polymedication regimes increase the risk of medication-related problems ( MRPs ) and hospitalization .
Effective , well-organized medication management could avoid MRPs and their clinical outcomes .
OBJECTIVE Identify medication management models and analyze their impact on managing and preventing MRPs for polymedicated , home-dwelling older adults .